Durect Stock Today

DRRX Stock  USD 1.01  0.15  17.44%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 80

 
High
 
Low
High
Durect is trading at 1.01 as of the 24th of November 2024; that is 17.44% increase since the beginning of the trading day. The stock's open price was 0.86. Durect has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Durect are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
28th of September 2000
Category
Healthcare
Classification
Health Care
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California. Durect Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 31.04 M outstanding shares of which 978.34 K shares are currently shorted by private and institutional investors with about 17.89 trading days to cover. More on Durect

Moving together with Durect Stock

  0.76VALN Valneva SE ADRPairCorr

Moving against Durect Stock

  0.68BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.47EWTX Edgewise TherapeuticsPairCorr
  0.45GILD Gilead SciencesPairCorr
  0.36KZR Kezar Life SciencesPairCorr
  0.32FBRX Forte Biosciences TrendingPairCorr

Durect Stock Highlights

Thematic IdeaPharmaceutical Products (View all Themes)
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Pharmaceutical Products, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.270.1892
Significantly Up
Slightly volatile
Gross Profit Margin1.020.7991
Significantly Up
Slightly volatile
Total Current Liabilities14.7 M27 M
Way Down
Slightly volatile
Non Current Liabilities Total3.2 M3.4 M
Notably Down
Very volatile
Total Assets56.3 M45.2 M
Fairly Up
Slightly volatile
Total Current Assets43.1 M34.7 M
Fairly Up
Slightly volatile
Debt Levels
Durect can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Durect's financial leverage. It provides some insight into what part of Durect's total assets is financed by creditors.
Liquidity
Durect currently holds 20.75 M in liabilities with Debt to Equity (D/E) ratio of 0.68, which is about average as compared to similar companies. Durect has a current ratio of 4.35, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Durect's use of debt, we should always consider it together with its cash and equity.

Net Income

(29.01 Million)
Durect (DRRX) is traded on NASDAQ Exchange in USA. It is located in 10240 Bubb Road, Cupertino, CA, United States, 95014-4166 and employs 48 people. Durect is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.35 M. Durect conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 31.04 M outstanding shares of which 978.34 K shares are currently shorted by private and institutional investors with about 17.89 trading days to cover. Durect currently holds about 51.89 M in cash with (34.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check Durect Probability Of Bankruptcy
Ownership Allocation
Durect holds a total of 31.04 Million outstanding shares. Durect shows 5.7 percent of its outstanding shares held by insiders and 23.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Durect Ownership Details

Durect Stock Institutional Holders

InstituionRecorded OnShares
Accredited Investors Inc2024-09-30
87.6 K
Citadel Advisors Llc2024-09-30
74.7 K
Northern Trust Corp2024-09-30
50.3 K
Silverberg Bernstein Capital Management Llc2024-09-30
46.8 K
Gsa Capital Partners Llp2024-09-30
41.8 K
Tocqueville Asset Management L.p.2024-09-30
28.9 K
International Assets Investment Management, Llc2024-09-30
27.2 K
Raymond James & Associates2024-09-30
22.3 K
Actinver Wealth Management Inc.2024-09-30
21.3 K
Ingalls & Snyder Llc2024-09-30
M
Vanguard Group Inc2024-09-30
1.1 M
View Durect Diagnostics

Durect Historical Income Statement

At this time, Durect's Other Operating Expenses is fairly stable compared to the past year. Research Development is likely to rise to about 30.6 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 140.6 K in 2024. View More Fundamentals

Durect Stock Against Markets

Durect Corporate Management

James DVMCEO, CoFounderProfile
Jian MBACorporate FinanceProfile
Su YumExecutive OfficerProfile
Norman MDChief OfficerProfile
Keith MBACommercial DevelopmentProfile
Andrew MiksztalVP ScientistProfile

Additional Tools for Durect Stock Analysis

When running Durect's price analysis, check to measure Durect's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Durect is operating at the current time. Most of Durect's value examination focuses on studying past and present price action to predict the probability of Durect's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Durect's price. Additionally, you may evaluate how the addition of Durect to your portfolios can decrease your overall portfolio volatility.